Evan J. Lipson

Evan J. Lipson, MD

Associate Professor of Oncology
Melanoma and Cancer Immunology Programs
Bloomberg-Kimmel Institute for Cancer Immunotherapy
Johns Hopkins University School of Medicine
Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland

Explore Activities by Evan J. Lipson

Title
Format
Credit Type
Credits
Key Studies in Breast, Lung, Gastrointestinal, Genitourinary, and Skin Cancers: CCO Independent Conference Highlights of the 2023 ESMO Congress

Content Format:

Conference Coverage

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.50
An Expert’s Guide to ESMO 2023: A Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Advancing the Line With New Combination Therapies for Malignant Melanoma

Content Format:

Video

Credit Type:

ABIM MOC | AMA

Credits:

1.00
Melanoma Decision Support Tool

Content Format:

Tool

Credit Type:

--

Credits:

--
Think Tank on Melanoma: Optimizing Therapy for Patients in an Evolving Treatment Landscape

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Optimizing Therapy for Patients With Melanoma in an Evolving Treatment Landscape

Content Format:

Slideset

Credit Type:

--

Credits:

--
Experts Address Questions on the Use of Immunotherapy for Resectable and Unresectable Melanoma in Today’s Practice

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Critical Conversations in Melanoma: Expert Perspectives on Immunotherapy in Resectable and Unresectable Disease

Content Format:

Video

Credit Type:

AMA

Credits:

1.00
Critical Conversations in Melanoma: Expert Perspectives on Immunotherapy in Resectable and Unresectable Disease

Content Format:

Slideset

Credit Type:

--

Credits:

--
Advancing the Line With New Combination Therapies for Malignant Melanoma

Content Format:

Slideset

Credit Type:

--

Credits:

--
Targeting LAG-3 to Potentiate Antitumor Immune Activity: Expert Guidance on Molecular Function and Clinical Application

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.75
Targeting LAG-3 to Potentiate Antitumor Immune Activity: Expert Guidance on Molecular Function and Clinical Application

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
What to Know About the Novel Anti–LAG-3 Checkpoint Inhibitor Relatlimab in Melanoma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Key Studies in Skin Cancer: Independent Conference Coverage of the 2021 ASCO Scientific Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
An Expert’s Guide to ASCO 2021: A Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Medical Minute: Treatment Algorithms for Melanoma

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Medical Minute: Emerging Therapies and Novel Combinations for Melanoma Treatment

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Medical Minute: Biomarker-Driven Treatment Selection in Melanoma

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25